Health analysis for Tassutuvan Verokarhu

Generations:

Please note: If no health information is shown for an animal, this does not necessarily mean that the animal is healthy but merely that no information was provided.

Tassutuvan Verokarhu FIN 2020, COI 1.69 %	Tassutuvan Rantaleijona FIN 2012, COI 1.83 % * Year of death: 2023 Cause of death: Unspecified/Other Cancer -	Dagolas Quumakalle FIN 2010, COI 0.56 % *	Aegirsson Duncan Mac Leod FRA 2008, COI 2.62 % * Breed relevant health information: Hips Fair / B1 / 4-6 / B / 11-18 - Progressive retinal atrophy (prcd-PRA) N/mut (carrier) -
		Dagolas Quumakalle FIN 2010, COI 0.56 % *	Dagolas Haltiatar FIN 2007, COI 1.40 % * Breed relevant health information: Hips Excellent / A1 / 0 / A / 0-4 (no >3/hip) - 30/10/2009
		Naavatassu Bess FIN 2010, COI 1.25 % *	Turnukan Vili Vilperi FIN 2006, COI 1.39 % * Year of death: 2010
		Naavatassu Bess FIN 2010, COI 1.25 % *	Tassutuvan Amrita FIN 2005, COI 2.56 % * Year of death: 2015
	Meikäläisen Syyshertta FIN 2015, COI 1.57 % *	Fihtolas Ekoteko FIN 2009, COI 1.19 % *	Fihtolas Garviainen FIN 2005, COI 1.37 % *
		Fihtolas Ekoteko FIN 2009, COI 1.19 % *	Fihtolas Åfelia FIN 2006, COI 1.50 % *
		Dagolas Åmenainen FIN 2012, COI 4.20 %	Turnukan Ivalo FIN 2011, COI 3.67 % Breed relevant health information: Hips Excellent / A1 / 0 / A / 0-4 (no >3/hip) - 2/4/2012
		Dagolas Åmenainen FIN 2012, COI 4.20 %	Dagolas Kullannuppu FIN 2008, COI 1.41 % * Breed relevant health information: Hips Excellent / A1 / 0 / A / 0-4 (no >3/hip) - 15/10/2010

* COI cannot be reliably calculated due to incomplete generations in the pedigree!

Pedigree generated by breedarchive.com at 1/4/2025

The information on this page shows a snap-shot of the relevant data available in The Breed Archive at the time the page was created, with no guarantee with regard to the completeness or correctness of the data (the data having been provided by the user community). The Breed Archive accepts no liability with respect to the information shown or any conclusions drawn from it.